NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 243 filers reported holding NEOGENOMICS INC in Q4 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $315,409 | -10.0% | 25,643 | +17.6% | 0.00% | -50.0% |
| Q2 2023 | $350,422 | -7.7% | 21,806 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $379,642 | +112.8% | 21,806 | +12.9% | 0.00% | +100.0% |
| Q4 2022 | $178,415 | +32.2% | 19,309 | +23.5% | 0.00% | 0.0% |
| Q3 2022 | $135,000 | +6.3% | 15,635 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $127,000 | -33.2% | 15,635 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $190,000 | -64.4% | 15,635 | 0.0% | 0.00% | -66.7% |
| Q4 2021 | $533,000 | -2.6% | 15,635 | +37.9% | 0.00% | 0.0% |
| Q3 2021 | $547,000 | +6.8% | 11,340 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $512,000 | -6.4% | 11,340 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $547,000 | -21.7% | 11,340 | -12.6% | 0.00% | -25.0% |
| Q4 2020 | $699,000 | +56.7% | 12,982 | +7.5% | 0.00% | +33.3% |
| Q3 2020 | $446,000 | +19.3% | 12,081 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $374,000 | +40.6% | 12,081 | +25.4% | 0.00% | +50.0% |
| Q1 2020 | $266,000 | +9.5% | 9,632 | +16.1% | 0.00% | 0.0% |
| Q4 2019 | $243,000 | +120.9% | 8,298 | +43.6% | 0.00% | +100.0% |
| Q3 2019 | $110,000 | -0.9% | 5,778 | +14.7% | 0.00% | 0.0% |
| Q2 2019 | $111,000 | +7.8% | 5,039 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $103,000 | +41.1% | 5,039 | -13.4% | 0.00% | 0.0% |
| Q4 2018 | $73,000 | -18.0% | 5,818 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $89,000 | +17.1% | 5,818 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $76,000 | +61.7% | 5,818 | 0.0% | 0.00% | – |
| Q1 2018 | $47,000 | -9.6% | 5,818 | 0.0% | 0.00% | – |
| Q4 2017 | $52,000 | +33.3% | 5,818 | +64.8% | 0.00% | – |
| Q3 2017 | $39,000 | +21.9% | 3,530 | 0.0% | 0.00% | – |
| Q2 2017 | $32,000 | +14.3% | 3,530 | 0.0% | 0.00% | – |
| Q1 2017 | $28,000 | -6.7% | 3,530 | 0.0% | 0.00% | – |
| Q4 2016 | $30,000 | -38.8% | 3,530 | -41.2% | 0.00% | -100.0% |
| Q3 2016 | $49,000 | +2.1% | 6,001 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $48,000 | – | 6,001 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,785,605 | $86,138,000 | 34.19% |
| PERKINS CAPITAL MANAGEMENT INC | 157,750 | $7,610,000 | 4.71% |
| Blue Water Life Science Advisors, LP | 222,222 | $10,719,000 | 3.49% |
| First Light Asset Management, LLC | 1,055,960 | $50,940,000 | 3.36% |
| Ranger Investment Management | 810,956 | $39,121,000 | 2.09% |
| Bullseye Asset Management LLC | 108,054 | $5,212,000 | 1.81% |
| Lombard Odier Asset Management (Switzerland) SA | 584,281 | $28,186,000 | 1.75% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 998,858 | $48,185,000 | 1.67% |
| EMERALD ADVISERS, LLC | 904,298 | $43,623,000 | 1.58% |
| Soleus Capital Management, L.P. | 190,556 | $9,192,000 | 1.43% |